Improvements in medical therapy, carotid-artery stenting, and carotid endarterectomy call into question the preferred ...

This feature about a man hospitalized for uncomplicated diverticulitis who is found to have high blood pressure offers a case vignette accompanied by two essays, one supporting watchful waiting and ...

Esophageal cancer is a highly lethal disease and the seventh leading cause of cancer-related death. In 2022, there were 511,000 new cases of esophageal cancer and 445,000 deaths from esophageal cancer ...

Gastric and gastroesophageal junction cancers remain a major global health challenge, with a high risk of recurrence despite surgery and perioperative chemotherapy. The standard perioperative regimen, ...

Protecting health is a team sport — yet the public health and clinical care systems meant to advance this goal have been siloed for too long.

No medications are currently approved for the treatment of nonmonogenic, nonsyndromic obesity in children younger than 12 years of age. Although the use of liraglutide has been shown to induce weight ...

The management of carotid-artery stenosis that has not caused recent symptoms — asymptomatic carotid stenosis — has been controversial. Clinical trials that began more than 30 years ago showed a small ...

For decades, the guidance was simple: treat a provoked venous thromboembolism (VTE) — one caused by a transient factor such as surgery, trauma, or immobility — for 3 to 6 months, stop, and move on. 1 ...

The addition of pembrolizumab to trastuzumab and chemotherapy in patients with gastric cancer improved both progression-free and overall survival as compared with trastuzumab and chemotherapy alone.

This feature about a man with obesity offers a case vignette accompanied by two essays, one supporting initiation of semaglutide therapy and the other recommending bariatric and metabolic surgery.

To the Editor: Barshak and colleagues (May 11 issue) 1 report a case of mpox conjunctivitis in a 31-year-old immunocompetent man who was treated with tecovirimat. In their discussion of the ocular ...